Resources

ECCO guidelines on therapeutics disease in Crohn’s disease: Medical treatment (2019)

Crohn’s disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in progressive bowel damage and disability.1 CD can affect individuals of any age, from children to the elderly,2,3 and may cause significant morbidity and impact on quality of life. Up to one-third of patients present with complicated behaviour [strictures, fistula, or abscesses] at diagnosis.4 Most patients over time will develop a complication, with roughly 50% of patients requiring surgery within 10 years of diagnosis.5–7 As the precise aetiology of CD remains unknown, a curative therapy is not yet available.8 Several agents are available for the medical treatment of CD. Medical agents include mesalazine [5-ASA], locally active steroids [such as budesonide], systemic steroids, thiopurines such as azathioprine [AZA] and mercaptopurine [MP], methotrexate [MTX], and biologic therapies (such as anti-tumour necrosis factor [TNF], anti-integrins, and anti-interleukin [IL] 12/23].

BSG-ACPGBI guidelines for the management of large non-pedunculated colorectal polyps

These guidelines provide an evidence-based framework for the management of patients with large nonpedunculated colorectal polyps.

BSG/ACPGBI/PHE Post-polypectomy and post-colorectal cancer resection surveillance guidelines

These guidelines have been reviewed and endorsed by BSG CSSC and ACPGBI in 2020.

Joint ACPGBI and The Duke's Club statement on colonoscopy training

A publication by the ACPGBI Colonoscopy Subcommittee

The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery

There is a requirement for an expansive and up to date review of the management of emergency colorectal conditions seen in adults. The primary objective is to provide detailed evidence-based guidelines for the target audience of general and colorectal surgeons who are responsible for an adult population and who practise in Great Britain and Ireland.

Pruritus ani: Scenario: Management

European Society of ColoProctology: guideline for haemorrhoidal disease

The goal of this European Society of ColoProctology project was to establish a multidisciplinary, international guideline for haemorrhoidal disease (HD) and to provide guidance on the most effective (surgical) treatment for patients with HD.

Pilonidal sinus disease

Pilonidal sinus disease is an inflammatory skin condition that usually occurs in the midline of the natal cleft (although there have been few reported cases involving other parts of the body, such as on the scalp, axilla, groin, and between the fingers). The term 'pilonidal' originates from the Latin words 'pilo' (hair) and 'nidus' (nest), implying a nest of hair. Pilonidal sinus may be asymptomatic, or present as an acute abscess (with or without cellulitis) or a chronic cyst and/or sinus with persistent drainage and/or extensive subcutaneous tracts.

Surgery for constipation: systematic review and practice recommendations

C. H. Knowles, U. Grossi, M. Chapman, J. Mason, on behalf of the NIHR CapaCiTY working group, Pelvic floor Society

Surgery for constipation: systematic review and practice recommendations Graded practice and future research recommendations

C. H. Knowles, U. Grossi, E. J. Horrocks, D. Pares, P. F. Vollebregt, M. Chapman, S. Brown, M. Mercer-Jones, A. B. Williams, Y. Yiannakou, R. J. Hooper, N. Stevens, J. Mason, on behalf of the NIHR CapaCiTY working group, The Pelvic floor Society and, European Society of Coloproctology